Clinical Trial Update: Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

View source ↗

Summary

A completed clinical trial sponsored by the National Cancer Institute studied immune responses in healthy subjects and in patients with immunodeficiency disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Immunodeficiency

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Immunologic Deficiency Syndromes, Neoplasms | Status: COMPLETED